Key Takeaways A less expensive, generic version of the GLP-1 medication Victoza is coming to market Hopefully, the approval will help prevent shortages triggered by demand for injectable weight loss drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) There is still no generic version of Ozempic THURSDAY, Dec
Unlock the potential of Lipo-C injections and experience a renewed sense of energy, vitality, and confidence
The regulatory body maintains a 180-day standard review timeline for generic submissions, with potential approvals expected throughout 2026
Melnik BC (2015) Linking diet to acne metabolomics, inflammation, and comedogenesis: an update
PMID 39025385
Healthcare providers give propionyl-L-carnitine intravenously (by IV) for treating PVD and intermittent claudication